Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fahimeh Shahriyary
Institution:
Iran University of Medical Sciences
Observed institution:
Iran University of Medical Sciences
ORCID:
0009-0007-2814-3555
Observed ORCID:
0009-0007-2814-3555
OpenAlex ID:
A5087621448
Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy
2023
·
Seyed Esmaeil Ahmadi
, Maral Soleymani
, et al.
·
Cancer Gene Therapy
·
103
PDF
A systematic review of second-generation FLT3 inhibitors for treatment of patients with relapsed/refractory acute myeloid leukemia
2024
·
Alireza Mohebbi
, Fahimeh Shahriyary
, et al.
·
Leukemia Research
·
14
Angiogenesis, coagulation, and fibrinolytic markers in acute promyelocytic leukemia (NB4): An evaluation of melatonin effects
2023
·
Mohammad Reza Amirzargar
, Fahimeh Shahriyary
, et al.
·
Journal of Pineal Research
·
7
Resveratrol decreases extracellular traps (ETs) in acute promyelocytic leukemia (NB4) cells
2025
·
Mahshid Vafajoo
, Minoo Shahidi
, et al.
·
PLoS ONE
·
3
PDF
Resveratrol and tetrahydroisoquinoline effects on neutrophil sensitivity to NETosis formation in low‐risk essential thrombocythemia patients
2024
·
Fahimeh Shahriyary
, Mohammad Reza Amirzargar
, et al.
·
European Journal Of Haematology
·
2
Retrospective analysis of COVID-19 clinical and laboratory data: Constructing a multivariable model across different comorbidities
2024
·
Mahdieh Shokrollahi Barough
, Mohammad Darzi
, et al.
·
Journal of Infection and Public Health
·
1
Tetrahydroisoquinoline reduces angiogenesis by interacting myeloma cells with HUVECs mediated by extracellular vesicles
2024
·
Ahmad Kooshari
, Fahimeh Shahriyary
, et al.
·
Medical Oncology
·
1
Show more works
View as search
Works count:
7
Citation count:
131
H-index:
3
I10-index:
2
Year
Topic
Type